Health Condition 1: J851- Abscess of lung with pneumonia Health Condition 2: J168- Pneumonia due to other specified infectious organisms Health Condition 3: J981- Pulmonary collapse Health Condition 4: J99- Respiratory disorders in diseasesclassified elsewhere Health Condition 5: J22- Unspecified acute lower respiratory infection
Conditions
Interventions
Intervention1: 10 sprays of 10% topical lignocaine: 10 sprays of 10% topical lignocaine would be applied on the pharynx prior to flexible bronchoscopy and the outcomes would be assessed
Control Interv
Sponsors
Department of Pulmonary Medicine and Sleep Disorders
Eligibility
Inclusion criteria
Inclusion criteria: All adults more than or equal to 18 yrs of age undergoing flexible bronchoscopy
Exclusion criteria
Exclusion criteria: 1) Uncontrolled hypertension SBP >180 mm Hg 2) Symptomatic coronary artery disease 3) Pregnancy 4) Not giving informed consent for the procedure 5) Hypoxemia (oxygen saturation [by pulse oximetry] less than 92% with Fio2 ofmore than or equal to 0.3 6) Bronchoscopy performed through an artificial airway
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Operator rated overall procedure satisfaction on Visual Analogue scale (VAS)Timepoint: At study completion approximately 12 months | — |
Secondary
| Measure | Time frame |
|---|---|
| 1) Operator rated cough on VAS 2) Time from introduction to reaching the vocal cords 3) Patient willingness to return for repeat bronchoscopy 4) Cumulative lignocaine dose: Patients receiving more than 8.2 mg/kg, patients receiving more than 6 mg/kg lignocaine 5) Total dose of midazolam and fentanyl required 7) ComplicationsTimepoint: At study completion approximately 12 months | — |
Countries
India
Contacts
Public ContactDr Karan Madan
AIIMS New Delhi
Outcome results
None listed